An anti-mycobacterial bisfunctionalized sphingolipid and new bromopyrrole alkaloid from the Indonesian marine sponge Agelas sp

In the course of our studies on anti-mycobacterial substances from marine organisms, the known dimeric sphingolipid, leucettamol A ( 1 ), was isolated as an active component, together with the new bromopyrrole alkaloid, 5-bromophakelline ( 2 ), and twelve known congeners from the Indonesian marine s...

Full description

Saved in:
Bibliographic Details
Published inJournal of natural medicines Vol. 71; no. 3; pp. 531 - 536
Main Authors Abdjul, Delfly B., Yamazaki, Hiroyuki, Kanno, Syu-ichi, Tomizawa, Ayako, Rotinsulu, Henki, Wewengkang, Defny S., Sumilat, Deiske A., Ukai, Kazuyo, Kapojos, Magie M., Namikoshi, Michio
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.07.2017
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In the course of our studies on anti-mycobacterial substances from marine organisms, the known dimeric sphingolipid, leucettamol A ( 1 ), was isolated as an active component, together with the new bromopyrrole alkaloid, 5-bromophakelline ( 2 ), and twelve known congeners from the Indonesian marine sponge Agelas sp. The structure of 2 was elucidated based on its spectroscopic data. Compound 1 and its bis TFA salt showed inhibition zones of 12 and 7 mm against Mycobacterium smegmatis at 50 μg/disk, respectively, while the N,N’ -diacetyl derivative ( 1a ) was not active at 50 μg/disk. Therefore, free amino groups are important for anti-mycobacterial activity. This is the first study to show the anti-mycobacterial activity of a bisfunctionalized sphingolipid. Compound 13 exhibited weak PTP1B inhibitory activity (29% inhibition at 35 μM).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1340-3443
1861-0293
DOI:10.1007/s11418-017-1085-6